Statera Biopharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $28,829,506.
Profit Margin
| 2013 | 0 | -17.26B | |
|---|---|---|---|
| 2014 | 0 | 1.62B | |
| 2015 | 0 | -12.63M | |
| 2016 | 0 | -2.65M | |
| 2017 | 0 | -9.70M | |
| 2018 | 0 | -3.61M | |
| 2019 | 0 | -3.34M | |
| 2020 | 0 | -13.22M | |
| 2021 | 0 | -174.40M |
STAB Income Statement (2013 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 488.31K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | -488.31K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating exp. | |||||||||
Research and development | 11.83M | 5.26M | 587K | 3.61M | 5.04M | 6.49M | 7.14M | 9.65B | 19.52B |
Selling and marketing | 79.43K | 2.40K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 28.82M | 10.50M | 2.81M | 5.93M | 7.54M | 9.87M | 13.49M | 18.12B | 31.56B |
Operating income | 38.67M | -10.50M | -2.81M | -4.79M | -5.60M | -6.35M | -10.79M | -14.42B | -23.07B |
Other income (expenses), net | -140.55M | -1.59M | -409.84K | 1.18M | -4.10M | 3.69M | -1.84M | 16.05B | 5.81B |
Income before tax | -101.87M | -12.09M | -3.22M | -3.61M | -9.70M | -2.65M | -12.63M | 1.62B | -17.26B |
Income tax expense | 72.53M | 1.13M | 124.23K | 0 | -52.51K | 0 | 0 | 0 | 0 |
Net income | -174.40M | -13.22M | -3.34M | -3.61M | -9.70M | -2.65M | -12.63M | 1.62B | -17.26B |
Earnings per share | |||||||||
Basic EPS | -4.97 | -0.52 | -0.13 | -0.32 | -0.87 | -0.24 | -1.79 | 0.6 | -0.38 |
Diluted EPS | -4.97 | -0.52 | -0.13 | -0.32 | -0.87 | -0.24 | -1.79 | 0.6 | -0.38 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |